2025 annual financial data
MapLight Therapeutics 2025 Operating margin
MapLight Therapeutics 2025 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -169,083,000 USD and net income was -161,152,000 USD.
Operating cash flow was -138,137,000 USD.
Get free MapLight Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -169,083,000 USD
- Net income
- -161,152,000 USD
- Operating cash flow
- -138,137,000 USD